Singapore's semiconductor stocks: Customers' results point to an opportunity in the selloff

AEM Holdings, UMS Integration and Frencken Group have sold off sharply even as most of their key customers reported strong results and guided higher. We see this gap as an opportunity to enter. We upgrade UMS to BUY (from HOLD) and maintain BUY on AEM, although US midterm results add a new risk to the data centre buildout.

Tan Qiuyi Charmaine
Tan Qiuyi Charmaine06 Nov 2026 5 Views
Singapore's semiconductor stocks: Customers' results point to an opportunity in the selloff

  • AEM Holdings, UMS Integration, and Frencken Group fell 16.4% to 27.6% between 15 October 2026 and 5 November 2026, as US rate fears, AI funding concerns, weak guidance from Intel, and the US midterm results hit sentiment.
  • UMS's customers offer the most direct read on equipment spending. Lam Research expects wafer fabrication equipment (WFE) spending to rise above USD 200 billion in 2027, from the mid-USD 150 billion range in 2026.
  • AEM's customers are more mixed. AMD’s Data Center revenue rose 97% YoY in 3Q26 and is guided up about 50% QoQ in 4Q26, and ASE is expanding capacity, but Intel’s guidance was weak on PCs.
  • ASML, a key Frencken customer, guided 4Q26 sales up about 51% YoY at the midpoint. As Frencken's customer base is more diversified than AEM's and UMS's, ASML's outlook alone may not fully reflect Frencken's overall business prospects.
  • Data centre moratorium pledges could delay projects, particularly in Texas and Georgia. We see this mainly as a timing and cost risk for now, but most customer guidance predates the vote.

Singapore's semiconductor stocks have extended their losses since our 15 October sector report. On 5 November 2026, AEM Holdings (SGX: AWX) closed at SGD 6.37, UMS Integration (SGX: 558) at SGD 1.78 and Frencken Group (SGX: E28) at SGD 1.84, down 27.6%, 23.6% and 16.4% respectively.

The selloff began in mid-October as faster US inflation lifted bets on further Federal Reserve hikes and AI funding concerns resurfaced. It deepened on 30 October after Alphabet's record one-day fall and Intel's weak guidance, and again this week after the US midterm elections.

The three companies' own 3Q26 figures are not yet available, but most of their key customers have reported. We use these results as a read-through to demand rather than a direct measure of orders, as customer shares are not fully disclosed. For Applied Materials, which reports on 12 November, we use its guidance for fiscal 4Q26, which ended on 25 October 2026.

Related article: Singapore's semiconductor stocks: Selloff opens an entry point as the upcycle holds

Related article: Intel 3Q26: PCs Break the Guide; Maintain SELL at Lower TP

Related article: Lam Research 1QFY27 earnings: Record results, but shares fell. Why we see a buying opportunity

Key customers: strong demand, with Intel the main exception

Table 1: Latest results of key customers

Customer

Customer of

Latest revenue

Most relevant measure

Latest quarter guidance

AMD

AEM (understood to be its fabless AI/HPC customer)

USD 13.4 billion (+45% YoY)

Data Center: USD 8.5 billion (+97% YoY)

About USD 17 billion, ±3%

Intel

AEM (PC/Foundry customer)

USD 16.5 billion (+21% YoY)

DCAI: USD 7.3 billion (+78% YoY)

USD 15 billion to USD 16 billion

ASE Technology

AEM (strategic partner)

NTD 244.2 billion (+45% YoY)

Testing: NTD 26.3 billion (+43% YoY)

ATM revenue +11% to +13% QoQ

Applied Materials

UMS (key customer)

Reports on 12 November

Guided Semiconductor Systems for Fiscal 4Q26 (to 25 Oct 2026): about USD 7.9 billion (+12% QoQ)

Guided Fiscal 4Q26 (to 25 Oct 2026) revenue USD 10.25 billion, ±USD 0.5 billion

Lam Research

UMS (understood to be its new major customer)

USD 8.22 billion (+54% YoY)

Memory at 46% of systems revenue

USD 8.6 billion, ±USD 0.4 billion

ASML

Frencken (key customer)

EUR 11.7 billion (+55% YoY)

Net system sales: EUR 8.4 billion (+51% YoY)

EUR 14.2 billion to EUR 15.2 billion

Source: Company earnings materials. Periods are 3Q26 or the quarter ended September 2026, unless stated.


UMS: the most direct read on equipment spending

Lam's outlook is the clearest positive. Its WFE forecast implies growth of about 30% in 2027 on our calculation, and customer visibility extends through 2028. Applied Materials' guidance points the same way. It guided fiscal 4Q26 (ended 25 October 2026) revenue to USD 10.25 billion, up about 51% YoY at the midpoint, with Semiconductor Systems revenue of about USD 7.9 billion. It is also further raising its 2026 Semiconductor Systems expectations and expects another strong growth year in 2027.

This demand meets a capacity constraint at UMS, where management has described near-term components capacity as tight. Its share placement should fund automation in Penang and a new factory in Vietnam, while 1H26 revenue from Malaysia and South Korea, the markets tied to its new major customer, rose 81.9% YoY.

Higher equipment spending may not reach UMS at the same pace, however. Lam's December-quarter guidance was held back as some component suppliers struggled to keep pace, with delayed shipments expected to move into the March quarter. This points to tight supply rather than weak demand.

With UMS’s own components capacity tight, we think it could be part of that bottleneck, although neither company has said so. If so, Lam’s higher spending would reach UMS only as fast as UMS adds capacity, making the timing of its Penang automation and Vietnam factory the key risk.

AEM: the highest growth, but the most mixed signals

AMD gives AEM the strongest support. It guided Data Center revenue up about 50% QoQ in 4Q26 and expects server revenue to double YoY in 2027, mostly on units and core counts and less so on ASPs. This matters because we think AEM’s test equipment demand depends more on chip volumes and test complexity than on selling prices. AEM has not disclosed how far its exposure extends to AMD's AI GPUs, however.

ASE adds a longer-dated opportunity, with testing revenue up 43% YoY and its ATM lines at or near full utilisation. No ASE-related revenue or backlog has been disclosed at AEM, so we treat this as upside rather than a forecast driver.

Intel is the main concern. Its 78% YoY DCAI revenue growth in 3Q26 came mainly from a 54% rise in server ASPs, driven by premium mix, while server volume rose only 10%. As think AEM’s demand depends more on chip volumes and test complexity than on selling prices, Intel’s revenue overstates the read-through. Client volume also fell 14%, and CCPG revenue is guided down more than 20% QoQ in 4Q26. As AEM's latest investor materials do not split its Intel business between server and client products, we cannot assume Intel's server strength insulates AEM.

Frencken: ASML offers support to a more diversified business

Frencken has a more diversified customer base than AEM and UMS, so we treat ASML's results as supporting evidence rather than a main driver. ASML's sales rose 55% YoY in 3Q26, and its ArFi lithography unit sales rose to 40 from 23 in 2Q26. Semiconductor equipment subsystems make up about 50% of Frencken's revenue.

Softer European Analytical Life Sciences demand kept 1H26 revenue flat. Thermo Fisher, another key customer, grew Analytical Instruments revenue about 6% YoY in 3Q26, but this global figure does not show that Frencken's European weakness has eased.

Overall, we view ASML’s strength to be supportive for Frencken’s semiconductor half. However, Frencken’s growth is likely to stay below AEM’s and UMS’s until European life-sciences demand recovers.

US midterms: a timing risk for data centres, not a demand risk for now

The midterm results add a policy risk that customer guidance has not fully tested. Democrats Gina Hinojosa and Keisha Lance Bottoms won the Texas and Georgia governorships after campaigning in part on data centre moratoriums. Texas accounts for about a quarter of US data centre capacity due by 2030, according to GLJ Research, while CBRE ranks Atlanta as the most active US data centre construction market.

We do not expect a broad, sharp slowdown. Most 2027 capacity is already under construction, decisions are split across city, county and state officials, and developers can move to other states. GLJ Research said projects with power, permits and steel should continue, while others could slip 12 to 18 months, move or not proceed. Much depends on how long any pause lasts: a conditional pause raises costs but keeps projects moving, while a pause until new legislation has no fixed end date.

We therefore see this mainly as a timing, location and cost risk rather than a change in AI computing demand. However, it matters for our names because delayed data centres could defer chip deployments, and eventually equipment orders. Hyperscalers' 2027 plans also predate the vote: Alphabet expects capex to increase significantly in 2027, Amazon expects to spend meaningfully more, and Microsoft expects capex to accelerate in the second half of its FY2027. Their next round of guidance will show whether those plans change.

Valuation: lower prices improve the entry point, not the risk

We leave our forecasts and target prices unchanged, so higher upside reflects lower share prices rather than a stronger thesis. Our forecasts do not assume any disruption from data centre moratoriums.

Table 2: Valuation after the selloff on 5 Nov 2026

AEM

UMS

Frencken

Share price (SGD)

6.37

1.78

1.84

Change since 15 October update

-27.6%

-23.6%

-16.4%

iFAST rating

BUY

BUY (from HOLD)

Not rated

Target price (SGD)

10.93

2.54

-

Upside

71.6%

42.7%

-

Fair P/E on FY2028E EPS

25x

20x

-

EPS growth FY2026E / FY2027E / FY2028E

389.1% / 34.8% / 24.1%

72.2% / 29.1% / 22.0%

10.9% / 14.1% / 18.1% (consensus)

Consensus forward P/E

24.0x

22.4x

18.3x

Source: Bloomberg Finance L.P., iFAST. Share prices as of 5 November 2026.

  • AEM (BUY, target price SGD 10.93) remains our preferred pick. We forecast about 29% annual EPS growth over FY2026–28, the fastest of the three, which supports a higher 71.6% upside. Intel’s weak outlook is the main risk to this view.
  • UMS (BUY, upgraded from HOLD, target price SGD 2.54) now offers 42.7% upside, compared with 9.0% on 15 October. Our forecasts are unchanged, so the upgrade reflects the lower share price. Lam’s and Applied Materials’ outlooks support demand, but UMS’s growth depends on its placement-funded capacity in Penang and Vietnam coming online in time.
  • Frencken (not rated) is the most diversified of the three in terms of customer base, but its slower expected growth means a lower multiple does not in itself make it cheaper.

Volatility is likely to persist, as Applied Materials’ results on 12 November and the companies’ own results could bring further swings. However, with 71.6% upside for AEM and 42.7% for UMS, we believe current prices more than compensate for that risk.

Table 3: Earnings table for AEM Holdings

FY25A

FY26E

FY27E

FY28E

P/E ratio (x)

32.2

24.4

18.1

14.6

Earnings growth (%)

46.6%

389.1%

34.8%

24.1%

EPS (SGD)

0.0535

0.2614

0.3523

0.4373

Target price (SGD)

10.93

Current price (SGD)

6.37

Upside potential (%)

71.6%

Source: Company data, iFAST estimates. FY25A P/E is based on the share price at the end of FY2025; FY26E to FY28E are based on share prices as of 5 November 2026.

Table 4: Earnings table for UMS Integration

FY25A

FY26E

FY27E

FY28E

P/E ratio (x)

24.3

22.1

17.1

14.0

Earnings growth (%)

2.6%

72.2%

29.1%

22.0%

EPS (SGD)

0.047

0.081

0.104

0.127

Target price (SGD)

2.54

Current price (SGD)

1.78

Upside potential (%)

42.7%

Source: Company data, iFAST estimates. FY25A P/E is based on the share price at the end of FY2025; FY26E to FY28E are based on share prices as of 5 November 2026.

Figure 1: AEM share price vs EPS chart

Figure 2: UMS share price vs EPS chart

Risks and what we are watching

The main risk is that funding concerns or moratoriums lower AI spending. These are cyclical businesses: UMS's EPS more than halved between 2022 and 2024.

  • Applied Materials on 12 November: results against guidance, and its comments on 2027 spending.
  • Company results: whether AEM, UMS and Frencken's own figures confirm their customers' demand.
  • Data centre policy: whether moratorium pledges become executive orders or legislation, and whether hyperscalers change their plans.
  • Supply and China: whether shortages or lower China revenue affect equipment makers' suppliers.

Note

iFAST Research rating system: iFAST Research employs a five-tier rating system: Buy (material upside potential, favourable risk-return); Accumulate (moderate upside, selectively add on weakness); Hold (limited upside, maintain existing positions); Trim (upside insufficient to justify a full position, reduce exposure on strength); and Sell (material downside risk, exit position).

Disclaimer

For specific disclosure, at the time of publication of this report, IFPL (via its connected and associated entities) holds a NIL position in the abovementioned securities. The analyst who produced this report holds a NIL position in the abovementioned securities.

This research report was prepared with the assistance of artificial intelligence (AI) tools. iFAST Financial Pte Ltd does not rely exclusively on AI for content generation; the content of this report, including all investment theses, ratings, price targets and conclusions, has been independently reviewed and verified by the research analyst(s) to ensure accuracy and professional integrity.

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://fsm.global/sg/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.

In this article

SGX: 558Delayed

UMS
SGD 1.700 -4.49%

SGX: AWXDelayed

AEM SGD
SGD 6.230 -2.20%

SGX: E28Delayed

Frencken
SGD 1.730 -5.98%

Stay updated with us on Telegram

Like us on Facebook

Follow us on Instagram

Watch our videos on YouTube